Abstract

We thank Dr Farina for his interest in our article, “A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.”1 We acknowledge that he is correct that the design of the study by Iida et al2 randomized patients to cilostazol plus aspirin versus ticlopidine plus aspirin and showed improved vascular patency after femoropopliteal endovascular intervention. The design was accurately reported in Table 2 but incorrectly stated in the text; a correction has been made to the online version of the article. Dr Farina points to 2 additional randomized trials that have also evaluated …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call